secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001104659-23-087830
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA Pharma receives Nasdaq bid price deficiency notice; has 180 days to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq letter on Aug 3, 2023 due to closing bid price below $1.00 for 30 consecutive business days.
- Non-compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on Global Select Market.
- Automatic 180-day cure period until Jan 30, 2024; must have $1.00 closing bid for 10 consecutive days.
- If still non-compliant by Jan 30, 2024, may qualify for a second 180-day period if certain requirements met.
- Evaluating options including reverse stock split; stock continues trading under "HOOK" with no immediate effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923087830/0001104659-23-087830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923087830/tm2322899d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-087830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer